Biologics Market 2027 by Types, Application, Technology, Opportunities, End Users and Regions | The Insight Partners

Biologics Market to 2027 - Global Analysis and Forecasts By Product (Monoclonal Antibodies, Cell Therapy, Vaccines, Recombinant Hormones/Proteins, and Gene Therapy), Application (Infectious Diseases, Oncology, Immunology, and Autoimmune Diseases) and Geography

Report Code: TIPRE00002765 | No. of Pages: 150 | Category: Pharmaceuticals | Status: Upcoming
Biologics are drugs in the form of genetically engineered proteins derivative of human genes. The biologics can be composed of proteins, sugars, or nucleic acids or complex combinations of these substances, or may be living entities such as cells and tissues. Advanced biotechnology techniques and complex processes are used to manufacture biologics, as they are important for biomedical research.

The biologics market is expected to witness growth during the forecast period due to rapid growth in rising incidence of chronic diseases and their diagnoses across the globe, increased availability of advanced diagnostics, rising government initiatives in healthcare and growing technological advancements in research and development. Also the increasing the demand for biologic drugs include rising regulatory convergence and better access to healthcare are expected to play a pivotal role in the biologics market.

The "Global Biologics Market Analysis to 2027" is a specialized and in-depth study of the biotechnology industry with a focus on the global market trend. The report aims to provide an overview of global biologics market with detailed market segmentation by product and application. The global biologics market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading market players and offers key trends and opportunities in the market.

The global biologics market is segmented on the basis of product and application. The product segment includes, monoclonal antibodies, cell therapy, vaccines, recombinant hormones/proteins, and gene therapy. By application, the market is segmented into infectious diseases, oncology, immunology, and autoimmune diseases.

The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the global biologics market based on product and application. It also provides market size and forecast till 2027 for overall biologics market with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 13 countries globally along with current trend and opportunities prevailing in the region.

North America is expected to hold the largest share in the biologics market. The large share of the segment is due to factors like the intensive R&D activities, innovative drug formulations, and a large number of clinical trials focused on large-molecule drug discovery. Asia-Pacific expecting high growth for the biologics market due to rise in favorable regulations for the approval of biologics, influx of global pharmaceutical companies setting up their biologics production facilities in emerging markets, majorly China.

The report analyzes factors affecting market from both demand and supply side and further evaluates market dynamics effecting the market during the forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the market in these regions.

The report also includes the profiles of key biologics market companies along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, products and services offered, financial information of last 3 years, key development in past five years. Some of the key players influencing the biologics market are F. Hoffmann-La Roche Ltd., AbbVie Inc., AstraZeneca, Bayer AG, Eli Lilly and Company, GlaxoSmithKline plc, Pfizer Inc., Merck & Co., Inc., Novartis AG, and CELGENE CORPORATION among others.

Table of Contents

1. INTRODUCTION
1.1. SCOPE OF STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE

2. KEY TAKEAWAYS

3. BIOLOGICS MARKET LANDSCAPE
3.1. MARKET OVERVIEW
3.2. MARKET SEGMENTATION
3.2.1. Biologics Market - By Product
3.2.2. Biologics Market - By Application
3.2.3. Biologics Market - By Region
3.2.3.1. By Country
3.3. PEST ANALYSIS
3.3.1. North America - PEST Analysis
3.3.2. Europe - PEST Analysis
3.3.3. Asia Pacific - PEST Analysis
3.3.4. Middle East and Africa - PEST Analysis
3.3.5. South and Central America - PEST Analysis

4. BIOLOGICS MARKET - KEY INDUSTRY DYNAMICS
4.1. KEY MARKET DRIVERS
4.2. KEY MARKET RESTRAINTS
4.3. KEY MARKET OPPORTUNITIES
4.4. FUTURE TRENDS
4.5. IMPACT ANALYSIS


5. BIOLOGICS MARKET - GLOBAL ANALYSIS
5.1. GLOBAL BIOLOGICS MARKET OVERVIEW
5.2. GLOBAL BIOLOGICS MARKET REVENUE FORECASTS AND ANALYSIS (US$ MN)
5.3. PERFORMANCE OF KEY PLAYERS
5.4. EXPERT OPINIONS

6. BIOLOGICS MARKET REVENUE AND FORECASTS TO 2027 - BY PRODUCT
6.1. OVERVIEW
6.2. PRODUCT MARKET REVENUE AND FORECASTS ANALYSIS (US$ MN)
6.3. MONOCLONAL ANTIBODIES MARKET
6.3.1. Overview
6.3.2. Monoclonal Antibodies Market Revenue Forecasts and Analysis (US$ Mn)
6.4. CELL THERAPY MARKET
6.4.1. Overview
6.4.2. Cell Therapy Market Revenue Forecasts and Analysis (US$ Mn)
6.5. VACCINES MARKET
6.5.1. Overview
6.5.2. Vaccines Market Revenue Forecasts and Analysis (US$ Mn)
6.6. RECOMBINANT HORMONES/PROTEINS MARKET
6.6.1. Overview
6.6.2. Recombinant Hormones/Proteins Market Revenue Forecasts and Analysis (US$ Mn)
6.7. GENE THERAPY MARKET
6.7.1. Overview
6.7.2. Gene Therapy Market Revenue Forecasts and Analysis (US$ Mn)


7. BIOLOGICS MARKET REVENUE AND FORECASTS TO 2027 - BY APPLICATION
7.1. OVERVIEW
7.2. APPLICATION MARKET REVENUE AND FORECASTS ANALYSIS (US$ MN)
7.3. INFECTIOUS DISEASES MARKET
7.3.1. Overview
7.3.2. Infectious Diseases Market Revenue Forecasts and Analysis (US$ Mn)
7.4. ONCOLOGY MARKET
7.4.1. Overview
7.4.2. Oncology Market Revenue Forecasts and Analysis (US$ Mn)
7.5. IMMUNOLOGY MARKET
7.5.1. Overview
7.5.2. Immunology Market Revenue Forecasts and Analysis (US$ Mn)
7.6. AUTOIMMUNE DISEASES MARKET
7.6.1. Overview
7.6.2. Autoimmune Diseases Market Revenue Forecasts and Analysis (US$ Mn)

8. NORTH AMERICA BIOLOGICS MARKET REVENUE AND FORECASTS TO 2027 - COUNTRY ANALYSIS
8.1. NORTH AMERICA BIOLOGICS MARKET OVERVIEW
8.2. NORTH AMERICA BIOLOGICS MARKET REVENUE FORECASTS AND ANALYSIS (US$ MN)
8.3. NORTH AMERICA BIOLOGICS MARKET REVENUE AND FORECASTS ANALYSIS - BY PRODUCT (US$ MN)
8.4. NORTH AMERICA BIOLOGICS MARKET REVENUE AND FORECASTS ANALYSIS - BY APPLICATION (US$ MN)
8.5. NORTH AMERICA BIOLOGICS MARKET REVENUE AND FORECASTS ANALYSIS - BY COUNTRY
8.6. US MARKET OVERVIEW
8.6.1. US Biologics Market Revenue Forecasts and Analysis - By Product (US$ Mn)
8.6.2. US Biologics Market Revenue Forecasts and Analysis - By Application (US$ Mn)
8.7. CANADA MARKET OVERVIEW
8.7.1. Canada Biologics Market Revenue Forecasts and Analysis - By Product (US$ Mn)
8.7.2. Canada Biologics Market Revenue Forecasts and Analysis - By Application (US$ Mn)
8.8. MEXICO MARKET OVERVIEW
8.8.1. Mexico Biologics Market Revenue Forecasts and Analysis - By Product (US$ Mn)
8.8.2. Mexico Biologics Market Revenue Forecasts and Analysis - By Application (US$ Mn)

9. EUROPE BIOLOGICS MARKET REVENUE AND FORECASTS TO 2027 - COUNTRY ANALYSIS
9.1. EUROPE BIOLOGICS MARKET OVERVIEW
9.2. EUROPE BIOLOGICS MARKET REVENUE FORECASTS AND ANALYSIS (US$ MN)
9.3. EUROPE BIOLOGICS MARKET REVENUE AND FORECASTS ANALYSIS - BY PRODUCT (US$ MN)
9.4. EUROPE BIOLOGICS MARKET REVENUE AND FORECASTS ANALYSIS - BY APPLICATION (US$ MN)
9.5. EUROPE BIOLOGICS MARKET REVENUE AND FORECASTS ANALYSIS - BY COUNTRY
9.6. UK MARKET OVERVIEW
9.6.1. UK Biologics Market Revenue Forecasts and Analysis - By Product (US$ Mn)
9.6.2. UK Biologics Market Revenue Forecasts and Analysis - By Application (US$ Mn)
9.7. GERMANY MARKET OVERVIEW
9.7.1. Germany Biologics Market Revenue Forecasts and Analysis - By Product (US$ Mn)
9.7.2. Germany Biologics Market Revenue Forecasts and Analysis - By Application (US$ Mn)
9.8. FRANCE MARKET OVERVIEW
9.8.1. France Biologics Market Revenue Forecasts and Analysis - By Product (US$ Mn)
9.8.2. France Biologics Market Revenue Forecasts and Analysis - By Application (US$ Mn)

10. ASIA PACIFIC BIOLOGICS MARKET REVENUE AND FORECASTS TO 2027 - COUNTRY ANALYSIS
10.1. ASIA PACIFIC BIOLOGICS MARKET OVERVIEW
10.2. ASIA PACIFIC BIOLOGICS MARKET REVENUE FORECASTS AND ANALYSIS (US$ MN)
10.3. ASIA PACIFIC BIOLOGICS MARKET REVENUE AND FORECASTS ANALYSIS - BY PRODUCT (US$ MN)
10.4. ASIA PACIFIC BIOLOGICS MARKET REVENUE AND FORECASTS ANALYSIS - BY APPLICATION (US$ MN)
10.5. ASIA PACIFIC BIOLOGICS MARKET REVENUE AND FORECASTS ANALYSIS - BY COUNTRY
10.6. JAPAN MARKET OVERVIEW
10.6.1. Japan Biologics Market Revenue Forecasts and Analysis - By Product (US$ Mn)
10.6.2. Japan Biologics Market Revenue Forecasts and Analysis - By Application (US$ Mn)
10.7. CHINA MARKET OVERVIEW
10.7.1. China Biologics Market Revenue Forecasts and Analysis - By Product (US$ Mn)
10.7.2. China Biologics Market Revenue Forecasts and Analysis - By Application (US$ Mn)
10.8. INDIA MARKET OVERVIEW
10.8.1. India Biologics Market Revenue Forecasts and Analysis - By Product (US$ Mn)
10.8.2. India Biologics Market Revenue Forecasts and Analysis - By Application (US$ Mn)

11. MIDDLE EAST AND AFRICA (MEA) BIOLOGICS MARKET REVENUE AND FORECASTS TO 2027 - COUNTRY ANALYSIS
11.1. MIDDLE EAST AND AFRICA (MEA) BIOLOGICS MARKET OVERVIEW
11.2. MIDDLE EAST AND AFRICA (MEA) BIOLOGICS MARKET REVENUE FORECASTS AND ANALYSIS (US$ MN)
11.3. MIDDLE EAST AND AFRICA (MEA) BIOLOGICS MARKET REVENUE AND FORECASTS ANALYSIS - BY PRODUCT (US$ MN)
11.4. MIDDLE EAST AND AFRICA (MEA) BIOLOGICS MARKET REVENUE AND FORECASTS ANALYSIS - BY APPLICATION (US$ MN)
11.5. MIDDLE EAST AND AFRICA (MEA) BIOLOGICS MARKET REVENUE AND FORECASTS ANALYSIS - BY COUNTRY
11.6. UAE MARKET OVERVIEW
11.6.1. UAE Biologics Market Revenue Forecasts and Analysis - By Product (US$ Mn)
11.6.2. UAE Biologics Market Revenue Forecasts and Analysis - By Application (US$ Mn)
11.7. SAUDI ARABIA MARKET OVERVIEW
11.7.1. Saudi Arabia Biologics Market Revenue Forecasts and Analysis - By Product (US$ Mn)
11.7.2. Saudi Arabia Biologics Market Revenue Forecasts and Analysis - By Application (US$ Mn)
11.8. SOUTH AFRICA MARKET OVERVIEW
11.8.1. South Africa Biologics Market Revenue Forecasts and Analysis - By Product (US$ Mn)
11.8.2. South Africa Biologics Market Revenue Forecasts and Analysis - By Application (US$ Mn)


12. SOUTH AND CENTRAL AMERICA BIOLOGICS MARKET REVENUE AND FORECASTS TO 2027 - COUNTRY ANALYSIS
12.1. SOUTH AND CENTRAL AMERICA BIOLOGICS MARKET OVERVIEW
12.2. SOUTH AND CENTRAL AMERICA BIOLOGICS MARKET REVENUE FORECASTS AND ANALYSIS (US$ MN)
12.3. SOUTH AND CENTRAL AMERICA BIOLOGICS MARKET REVENUE AND FORECASTS ANALYSIS - BY PRODUCT (US$ MN)
12.4. SOUTH AND CENTRAL AMERICA BIOLOGICS MARKET REVENUE AND FORECASTS ANALYSIS - BY APPLICATION (US$ MN)
12.5. SOUTH AND CENTRAL AMERICA BIOLOGICS MARKET REVENUE AND FORECASTS ANALYSIS - BY COUNTRY
12.6. BRAZIL MARKET OVERVIEW
12.6.1. Brazil Biologics Market Revenue Forecasts and Analysis - By Product (US$ Mn)
12.6.2. Brazil Biologics Market Revenue Forecasts and Analysis - By Application (US$ Mn)

13. INDUSTRY LANDSCAPE
13.1. ORGANIC GROWTH STRATEGIES
13.1.1. New Product Launches
13.1.2. Marketing & Promotional Activities
13.2. INORGANIC GROWTH STRATEGIES
13.2.1. Partnerships, Collaborations, and Joint Ventures
13.2.2. Mergers & Acquisitions

14. BIOLOGICS MARKET, KEY COMPANY PROFILES
14.1. F. HOFFMANN-LA ROCHE LTD.
14.1.1. Key Facts
14.1.2. Business Description
14.1.3. Financial Overview
14.1.4. Product Portfolio
14.1.5. SWOT Analysis
14.1.6. Key Developments

14.2. ABBVIE INC.
14.2.1. Key Facts
14.2.2. Business Description
14.2.3. Financial Overview
14.2.4. Product Portfolio
14.2.5. SWOT Analysis
14.2.6. Key Developments
14.3. ASTRAZENECA
14.3.1. Key Facts
14.3.2. Business Description
14.3.3. Financial Overview
14.3.4. Product Portfolio
14.3.5. SWOT Analysis
14.3.6. Key Developments
14.4. BAYER AG
14.4.1. Key Facts
14.4.2. Business Description
14.4.3. Financial Overview
14.4.4. Product Portfolio
14.4.5. SWOT Analysis
14.4.6. Key Developments
14.5. ELI LILLY AND COMPANY
14.5.1. Key Facts
14.5.2. Business Description
14.5.3. Financial Overview
14.5.4. Product Portfolio
14.5.5. SWOT Analysis
14.5.6. Key Developments
14.6. GLAXOSMITHKLINE PLC.
14.6.1. Key Facts
14.6.2. Business Description
14.6.3. Financial Overview
14.6.4. Product Portfolio
14.6.5. SWOT Analysis
14.6.6. Key Developments
14.7. PFIZER INC.
14.7.1. Key Facts
14.7.2. Business Description
14.7.3. Financial Overview
14.7.4. Product Portfolio
14.7.5. SWOT Analysis
14.7.6. Key Developments
14.8. MERCK & CO., INC.
14.8.1. Key Facts
14.8.2. Business Description
14.8.3. Financial Overview
14.8.4. Product Portfolio
14.8.5. SWOT Analysis
14.8.6. Key Developments
14.9. NOVARTIS AG
14.9.1. Key Facts
14.9.2. Business Description
14.9.3. Financial Overview
14.9.4. Product Portfolio
14.9.5. SWOT Analysis
14.9.6. Key Developments
14.10. CELGENE CORPORATION
14.10.1. Key Facts
14.10.2. Business Description
14.10.3. Financial Overview
14.10.4. Product Portfolio
14.10.5. SWOT Analysis
14.10.6. Key Developments

15. APPENDIX
15.1. ABOUT THE INSIGHT PARTNERS
15.2. GLOSSARY OF TERMS
15.3. RESEARCH METHODOLOGY
The List of Companies

1. F. Hoffmann-La Roche Ltd.
2. AbbVie Inc.
3. AstraZeneca
4. Bayer AG
5. Eli Lilly and Company
6. GlaxoSmithKline plc.
7. Pfizer Inc.
8. Merck & Co., Inc.
9. Novartis AG
10. CELGENE CORPORATION
Select License Type
USD $3000
USD $4550
USD $6550
USD $8550

Free

20%

customization on Pre-Booking
Pre Book